Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04057144
Other study ID # 2019/503
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 20, 2019
Est. completion date August 2029

Study information

Verified date September 2022
Source St. Olavs Hospital
Contact Petter C Borchgrevink, md prof
Phone +47 72822494
Email petter.borchgrevink@ntnu.no
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

As non-pharmacological alternatives, psychosocial treatments have been recommended for chronic pain management. One such treatment is Acceptance and Commitment Therapy (ACT). ACT is a cognitive behavior therapy based on Relational Frame Theory, a comprehensive theory about language and cognition. This treatment intends to help patients identify values ("what is truly meaningful to them") and to set goals and take action according to their values. ACT has research support in the treatment of several mental health problems. Moreover patients are taught mindfulness skills to increase acceptance of pain, thoughts and feelings so that these will have less impact on functioning and action. Among patients with chronic pain, several small clinical trials have shown that ACT is more effective than other treatments in terms of increasing function and improving mental health. ACT in combination with mindfulness training has not been tested so far. Further methodologically robust trials are required. This study will therefore examine whether ACT is more effective for chronic pain than an education program, and whether adding daily mindfulness training will improve the outcome, in a large sample of patients from four multidisciplinary pain centers.


Recruitment information / eligibility

Status Recruiting
Enrollment 486
Est. completion date August 2029
Est. primary completion date August 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - referred to one of the pain clinics in Oslo (200), Trondheim (200), Bergen (100) or Tromsø (100) - primary diagnosis of chronic pain lasting for at least 6 months Exclusion Criteria: - severe somatic disease - severe mental disorder (ongoing mania, psychosis, suicidal ideation, substance abuse/addiction - not able to communicate in Norwegian - needing 24-hour personal assistance

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
ACT
Acceptance and commitment therapy (ACT) sessions, lead by 2 qualified therapists, using a manual based on Steven Hayes et al 1999 that was adapted to group therapy and includes all the dynamic processes of ACT.
mindfulness exercises and audio recordings
mindfulness exercises introduced in the ACT sessions. In addition daily home meditation exercises based on the program developed by Kabat-Zinn 2005 and with help of audio recordings.
Education program
Self-management education program. Information given by a qualified health professional on pain and symptom management, stress, sleep, eating habits, mental health problems. Group discussions about thoughts and experiences. communication skills and physical activity

Locations

Country Name City State
Norway Haukeland universitetssykehus Bergen
Norway Oslo universitetssykehus Oslo
Norway Norges arktiske universitet Tromsø
Norway St Olavs Hospital Trondheim

Sponsors (5)

Lead Sponsor Collaborator
St. Olavs Hospital Haukeland University Hospital, Norwegian University of Science and Technology, Oslo University Hospital, University Hospital of North Norway

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Other attentional functioning assessed by the Attention Network Test (Fan et al 2002) specifically designed to measure alerting, orienting and executive attention within a single testing session, which can be reported from the patients computer and lasts about 15 min 8 weeks after end of treatment
Other attentional functioning assessed by the Attention Network Test (Fan et al 2002) specifically designed to measure alerting, orienting and executive attention within a single testing session, which can be reported from the patients computer and lasts about 15 min 24 weeks after end of treatment
Other attentional functioning assessed by the Attention Network Test (Fan et al 2002) specifically designed to measure alerting, orienting and executive attention within a single testing session, which can be reported from the patients computer and lasts about 15 min 44 weeks after end of treatment
Primary pain intensity measured by the Norwegian Brief Pain Inventory (BPI) the Brief Pain Inventory includes four 0-10 numerical rating scales: for 'pain now', and for 'least pain', 'worst pain', and 'average pain' during the last 24 hours, with 0 = no pain to 10 = pain as bad as you can imagine. A pain severity index is calculated by adding the scores on the pain severity items 44 weeks after end of treatment
Secondary pain intensity measured by the Norwegian Brief Pain Inventory (BPI) the Brief Pain Inventory includes four 0-10 numerical rating scales: for 'pain now', and for 'least pain', 'worst pain', and 'average pain' during the last 24 hours, with 0 = no pain to 10 = pain as bad as you can imagine. A pain severity index is calculated by adding the scores on the pain severity items 8 weeks after end of treatment
Secondary pain intensity measured by the Norwegian Brief Pain Inventory (BPI) the Brief Pain Inventory includes four 0-10 numerical rating scales: for 'pain now', and for 'least pain', 'worst pain', and 'average pain' during the last 24 hours, with 0 = no pain to 10 = pain as bad as you can imagine. A pain severity index is calculated by adding the scores on the pain severity items 24 weeks after end of treatment
Secondary pain intensity measured by the Norwegian Brief Pain Inventory (BPI) the Brief Pain Inventory includes four 0-10 numerical rating scales: for 'pain now', and for 'least pain', 'worst pain', and 'average pain' during the last 24 hours, with 0 = no pain to 10 = pain as bad as you can imagine. A pain severity index is calculated by adding the scores on the pain severity items 3 years after end of treatment
Secondary physical function according to the SF-36 Health Survey 8 weeks after end of treatment
Secondary physical function according to the SF-36 Health Survey 24 weeks after end of treatment
Secondary physical function according to the SF-36 Health Survey 44 weeks after end of treatment
Secondary physical function according to the SF-36 Health Survey 3 years after end of treatment
Secondary mental health according to the SF-36 Health Survey 8 weeks after end of treatment
Secondary mental health according to the SF-36 Health Survey 24 weeks after end of treatment
Secondary mental health according to the SF-36 Health Survey 44 weeks after end of treatment
Secondary mental health according to the SF-36 Health Survey 3 years after end of treatment
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain